Camphausen K - Search Results

1

A dosimetric analysis of dose escalation using two intensity-modulated radiation therapy techniques in locally advanced pancreatic carcinoma.

Brown MW, Ning H, Arora B, Albert PS, Poggi M, Camphausen K, Citrin D. Brown MW, et al. Among authors: camphausen k. Int J Radiat Oncol Biol Phys. 2006 May 1;65(1):274-83. doi: 10.1016/j.ijrobp.2006.01.003. Int J Radiat Oncol Biol Phys. 2006. PMID: 16618582

2

HLA restriction and TCR usage of T lymphocytes specific for a novel candidate autoantigen, X2 MBP, in multiple sclerosis.

Voskuhl RR, Robinson ED, Segal BM, Tranquill L, Camphausen K, Albert PS, Richert JR, McFarland HF. Voskuhl RR, et al. Among authors: camphausen k. J Immunol. 1994 Nov 15;153(10):4834-44. J Immunol. 1994. PMID: 7525716

3

Clinical trial of endorectal amifostine for radioprotection in patients with prostate cancer: rationale and early results.

Ménard C, Camphausen K, Muanza T, Sears-Crouse N, Smith S, Ben-Josef E, Coleman CN. Ménard C, et al. Among authors: camphausen k. Semin Oncol. 2003 Dec;30(6 Suppl 18):63-7. doi: 10.1053/j.seminoncol.2003.11.016. Semin Oncol. 2003. PMID: 14727242 Clinical Trial.

4

In vivo tumor imaging using a near-infrared-labeled endostatin molecule.

Citrin D, Scott T, Sproull M, Menard C, Tofilon PJ, Camphausen K. Citrin D, et al. Among authors: camphausen k. Int J Radiat Oncol Biol Phys. 2004 Feb 1;58(2):536-41. doi: 10.1016/j.ijrobp.2003.09.068. Int J Radiat Oncol Biol Phys. 2004. PMID: 14751525

5

Urinary VEGF and MMP levels as predictive markers of 1-year progression-free survival in cancer patients treated with radiation therapy: a longitudinal study of protein kinetics throughout tumor progression and therapy.

Chan LW, Moses MA, Goley E, Sproull M, Muanza T, Coleman CN, Figg WD, Albert PS, Ménard C, Camphausen K. Chan LW, et al. Among authors: camphausen k. J Clin Oncol. 2004 Feb 1;22(3):499-506. doi: 10.1200/JCO.2004.07.022. J Clin Oncol. 2004. PMID: 14752073 Clinical Trial.

6

Isoprostane levels in the urine of patients with prostate cancer receiving radiotherapy are not elevated.

Camphausen K, Ménard C, Sproull M, Goley E, Basu S, Coleman CN. Camphausen K, et al. Int J Radiat Oncol Biol Phys. 2004 Apr 1;58(5):1536-9. doi: 10.1016/j.ijrobp.2003.09.011. Int J Radiat Oncol Biol Phys. 2004. PMID: 15050334 Clinical Trial.

7

In vivo tumor imaging in mice with near-infrared labeled endostatin.

Citrin D, Lee AK, Scott T, Sproull M, Ménard C, Tofilon PJ, Camphausen K. Citrin D, et al. Among authors: camphausen k. Mol Cancer Ther. 2004 Apr;3(4):481-8. Mol Cancer Ther. 2004. PMID: 15078992

8

MRI-guided HDR prostate brachytherapy in standard 1.5T scanner.

Ménard C, Susil RC, Choyke P, Gustafson GS, Kammerer W, Ning H, Miller RW, Ullman KL, Sears Crouse N, Smith S, Lessard E, Pouliot J, Wright V, McVeigh E, Coleman CN, Camphausen K. Ménard C, et al. Among authors: camphausen k. Int J Radiat Oncol Biol Phys. 2004 Aug 1;59(5):1414-23. doi: 10.1016/j.ijrobp.2004.01.016. Int J Radiat Oncol Biol Phys. 2004. PMID: 15275727 Free PMC article.

9

System for prostate brachytherapy and biopsy in a standard 1.5 T MRI scanner.

Susil RC, Camphausen K, Choyke P, McVeigh ER, Gustafson GS, Ning H, Miller RW, Atalar E, Coleman CN, Ménard C. Susil RC, et al. Among authors: camphausen k. Magn Reson Med. 2004 Sep;52(3):683-7. doi: 10.1002/mrm.20138. Magn Reson Med. 2004. PMID: 15334592 Free PMC article.

10

Optical imaging of mice in oncologic research.

Citrin D, Camphausen K. Citrin D, et al. Among authors: camphausen k. Expert Rev Anticancer Ther. 2004 Oct;4(5):857-64. doi: 10.1586/14737140.4.5.857. Expert Rev Anticancer Ther. 2004. PMID: 15485319 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

307 results

Search Page

Filters